Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Jee Soo Park"'
Autor:
Jee Soo Park, Jongchan Kim, Jinhyung Jeon, Jongsoo Lee, Won Sik Jang, Seung Hwan Lee, Woong Kyu Han, Young Deuk Choi, Kyo Chul Koo, Kang Su Cho, Byung Ha Chung, Won Sik Ham
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background The role of cytoreductive nephrectomy (CN) in the treatment of metastatic renal cell carcinoma (mRCC) remains unclear in the immuno-oncology (IO) era. The results of two randomized trials, CARMENA and SURTIME, questioned the role
Externí odkaz:
https://doaj.org/article/51a4cd489eec473ebc47b4c88ddbaaf6
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/cc46b6e96c394af68424ab7b7c29f6e6
Autor:
Jee Soo Park, Myung Eun Lee, Jongchan Kim, Keunhee Oh, Namhee Lee, Minsun Jung, Won Sik Jang, Won Sik Ham
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Although a combination of immune checkpoint inhibitors (ICIs) is recommended as the first line treatment option for metastatic renal cell carcinoma (mRCC), several immune-related adverse events (irAEs) occur, especially hepatitis.
Externí odkaz:
https://doaj.org/article/92f2d6fdc5e5493a9c025cabe30dcb36
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionWe compared radical prostatectomy (RP) and radiotherapy (RT) as local therapies for primary tumors and examined their associations with survival outcomes and urinary tract complications in patients with oligometastatic prostate cancer (om
Externí odkaz:
https://doaj.org/article/15fce7afcf48464fae0d68007deb6597
Autor:
Dongwoo Kim, Narae Lee, Suk Hyun Lee, Hyun Jeong Kim, Hye-Suk Hong, Jee Soo Park, Nam-Hoon Cho, Young Deuk Choi, Won Sik Ham, Seung Hwan Lee, Woong Kyu Han, Mijin Yun
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract We evaluated the predictive value of 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography/CT (PET/CT) for extended pathological T (pT) stages (≥ pT3a) in Renal cell carcinoma (RCC) patients at staging. Thirty-eight RCC patie
Externí odkaz:
https://doaj.org/article/8b07f0bf06874b77a2d8b5b21cc0fac9
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract There is evidence that a history of benign prostatic hyperplasia increases the incidence of bladder cancer, and treatment with 5-alpha reductase inhibitor or androgen deprivation therapy reduces recurrence of non-muscle invasive bladder canc
Externí odkaz:
https://doaj.org/article/a2f8c1b853e0440ba848a6d93098b682
Publikováno v:
Cancer & Metabolism, Vol 9, Iss 1, Pp 1-11 (2021)
Abstract Background Visceral fat produces several hormones and cytokines associated with carcinogenesis and tumor progression. Herein, we investigated the association between visceral adiposity and target-gene mRNA expression in patients with localiz
Externí odkaz:
https://doaj.org/article/9aa46fbfe56e4de5a816f4cde7bd592a
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 6, Pp 442-446 (2019)
Purpose: The impact of family history on the diagnosis of the prostate cancer among Asian population remains controversial. We evaluated whether a positive family history of the prostate cancer in Korean men is associated with the diagnosis and aggre
Externí odkaz:
https://doaj.org/article/99dccc3ffe3849e3bdf7b809907fc52e
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2223 (2022)
Upper tract urothelial carcinoma (UTUC) is a relatively rare cancer, and much of the approach to treatment has been derived from strategies employed in treating bladder cancer. Radical nephroureterectomy (RNU) is regarded as the gold standard treatme
Externí odkaz:
https://doaj.org/article/36f4e0db0af9432da766742145c4e8d2
Autor:
Jee Soo Park, Hyo Jung Lee, Nam Hoon Cho, Jongchan Kim, Won Sik Jang, Ji Eun Heo, Won Sik Ham
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 17, Iss , Pp 371-377 (2019)
Some early-stage clear cell renal cell carcinomas (ccRCCs) of ≤7 cm are associated with a poor clinical outcome. In this study, we investigated molecular biomarkers associated with aggressive clinical T1 stage ccRCCs of ≤7 cm, which were used to
Externí odkaz:
https://doaj.org/article/f45cd20638f94b4fb4e26daa5f6f0e45